DE2716379A1 - Zusammensetzungen fuer die regulierung des menstrual- oder oestruszyklusses bei saeugern - Google Patents

Zusammensetzungen fuer die regulierung des menstrual- oder oestruszyklusses bei saeugern

Info

Publication number
DE2716379A1
DE2716379A1 DE19772716379 DE2716379A DE2716379A1 DE 2716379 A1 DE2716379 A1 DE 2716379A1 DE 19772716379 DE19772716379 DE 19772716379 DE 2716379 A DE2716379 A DE 2716379A DE 2716379 A1 DE2716379 A1 DE 2716379A1
Authority
DE
Germany
Prior art keywords
prostaglandin
deep
radical
luteolytic
synthetase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19772716379
Other languages
German (de)
English (en)
Inventor
Barrington John Albert Furr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE2716379A1 publication Critical patent/DE2716379A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19772716379 1976-04-14 1977-04-13 Zusammensetzungen fuer die regulierung des menstrual- oder oestruszyklusses bei saeugern Withdrawn DE2716379A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15249/76A GB1533928A (en) 1976-04-14 1976-04-14 Oestrus regulation

Publications (1)

Publication Number Publication Date
DE2716379A1 true DE2716379A1 (de) 1977-11-10

Family

ID=10055718

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772716379 Withdrawn DE2716379A1 (de) 1976-04-14 1977-04-13 Zusammensetzungen fuer die regulierung des menstrual- oder oestruszyklusses bei saeugern

Country Status (5)

Country Link
US (1) US4089951A (enExample)
JP (1) JPS52125631A (enExample)
DE (1) DE2716379A1 (enExample)
FR (1) FR2347931A1 (enExample)
GB (1) GB1533928A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369128A (en) * 1993-06-21 1994-11-29 Iowa State University Research Foundation, Inc. Method of synchronizing farrowing in swine
WO1997045113A1 (en) * 1996-05-30 1997-12-04 Sepracor Inc. Nsaids for regulating the reproductive cycle of domesticated animals
EP1610803B8 (en) * 2003-03-04 2011-09-14 AspenBio Pharma, Inc. LH for use in maintaining one or more pregnancies by inducing accessory corpus luteum formation.
WO2007047811A2 (en) * 2005-10-19 2007-04-26 Scott Josephson Improved reproductive management
US8096940B2 (en) * 2005-10-19 2012-01-17 Iversync Ii Llc Reproductive management

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3781429A (en) * 1972-09-29 1973-12-25 American Cyanamid Co Method of inhibiting ulcerogenesis induced by non-steroidal anti-inflammatory agents
US3937801A (en) * 1973-07-10 1976-02-10 American Home Products Corporation Reducing the incidence of gastrointestinal side effects during the treatment of inflammatory conditions with antiinflammatory drugs
US3928588A (en) * 1974-02-22 1975-12-23 Upjohn Co Method of reducing the undesirable gastrointestinal effects of prostaglandin synthetase inhibitors

Also Published As

Publication number Publication date
FR2347931A1 (fr) 1977-11-10
FR2347931B1 (enExample) 1980-02-22
GB1533928A (en) 1978-11-29
US4089951A (en) 1978-05-16
JPS52125631A (en) 1977-10-21

Similar Documents

Publication Publication Date Title
DE69305419T2 (de) Prostaglandin-I 2-Derivate enthaltende Haarwuchsmittel
DE3688296T2 (de) Arzneimittel zur behandlung von erbrechen.
DE3382641T2 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE3119051A1 (de) Mittel zur behandlung der augen
DE2405254A1 (de) Pharmazeutische oder kosmetische praeparate
DE69808619T2 (de) Prostaglandin-pharmazeutische-zusammensetzungen
ATE53038T1 (de) Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung.
DE2621214C3 (de) Verwendung von Stabilisatoren in Arzneimitteln mit Fumarsäuremonoäthylester und desen Mineralsalzen
DE3907649C2 (de) Arzneimittel, geeignet bei der Bekämpfung von Viren und zur Immunstimulierung
DE2360797C2 (de) Pharmazeutische Präparate
DE69224071T2 (de) Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
DE69133390T2 (de) Verwendung von angiotensin-ii-rezeptorantagonisten in der behandlung von hämorrhagischem schlaganfall
DE2716379A1 (de) Zusammensetzungen fuer die regulierung des menstrual- oder oestruszyklusses bei saeugern
EP0269899A2 (de) Verwendung von aromatischen Carbonsäureamiden
CH628632A5 (de) Verfahren zur herstellung von behensaeureestern von phenothiazinderivaten.
DE69420266T2 (de) Rektale zusammensetzungen enthaltend odansetron als freie base
DE2951671A1 (de) Arzneimittelzubereitung
DE69022206T2 (de) Aldosereduktasehemmer enthaltende Zubereitungen zur Behandlung von Geschwüren.
JPH03130228A (ja) 乾癬症の局所治療剤及びその製法
DE68912740T2 (de) Azazyklische Derivate mit harntreibender Wirkung.
DE2605243A1 (de) Pyrazolessigsaeurehaltiges arzneimittel
DE2038628B2 (de) N,N'-Di(carboxyalkyl)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69214647T2 (de) Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz
DE2918264A1 (de) Ophthalmikum und verfahren zu dessen anwendung
DE1593112B2 (de) o-Hydroxybenzoyl hydrazon oder o Alkyloxy benzoyl hydrazone der Benztraubensaure und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
8141 Disposal/no request for examination